Hacène Khiri Selected Research

Infections

1/2022	Online self-sampling kits for human immunodeficiency virus and other sexually transmitted infections: Feasibility, positivity rates, and factors associated with infections in France.
1/2017	HHV8 and Kaposi's sarcoma: should we really give up protease inhibitors in all HIV-infected patients?
1/2012	Detection of IL28B SNP DNA from buccal epithelial cells, small amounts of serum, and dried blood spots.
1/2010	Incident HPV 51 Infection After Prophylactic Quadrivalent Human Papillomavirus (Types 6, 11, 16, and 18) L1 Virus-Like Particle Vaccine Gardasil/Silgard.
4/2008	Methylenetetrahydrofolate reductase 677 T allele protects against persistent HBV infection in West Africa.
7/2006	Real-time PCR assays for hepatitis C virus (HCV) RNA quantitation are adequate for clinical management of patients with chronic HCV infection.
2/2006	Assessment of early virological response to antiviral therapy by comparing four assays for HCV RNA quantitation using the international unit standard: implications for clinical management of patients with chronic hepatitis C virus infection.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hacène Khiri Research Topics

Disease

7	Infections 01/2022 - 02/2006
2	Uterine Cervical Dysplasia 12/2018 - 01/2010
2	Chronic Hepatitis C 02/2006 - 12/2005
1	COVID-19 01/2021
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 12/2018
1	Hepatitis C 01/2018
1	Neoplasms (Cancer) 01/2017
1	Kaposi Sarcoma (Kaposi's Sarcoma) 01/2017
1	Viremia 01/2017
1	Chronic Hepatitis (Chronic Active Hepatitis) 12/2013
1	Sexually Transmitted Diseases (Sexually Transmitted Disease) 05/2010
1	Atypical Squamous Cells of the Cervix 02/2007
1	Virus Diseases (Viral Diseases) 02/2006
1	Coinfection 01/2006

Drug/Important Bio-Agent (IBA)

4	RNA (Ribonucleic Acid)IBA 05/2010 - 01/2006
3	DNA (Deoxyribonucleic Acid)IBA 12/2013 - 02/2007
2	Antiviral Agents (Antivirals)IBA 01/2018 - 02/2006
2	InterferonsIBA 12/2013 - 12/2005
1	SolutionsIBA 01/2022
1	AntigensIBA 01/2021
1	Protein Isoforms (Isoforms)IBA 12/2018
1	Messenger RNA (mRNA)IBA 12/2018
1	Integrase InhibitorsIBA 01/2017
1	Protease Inhibitors (Protease Inhibitor)IBA 01/2017
1	Hepatitis B e AntigensIBA 12/2013
1	NucleotidesIBA 12/2013
1	Hepatitis B Surface Antigens (HBsAg)FDA Link 12/2013
1	InterleukinsIBA 01/2012
1	18 16 11 Types 6 Human Papillomavirus Recombinant Vaccine Quadrivalent (Gardasil)FDA Link 01/2010
1	Virus-Like Particle VaccinesIBA 01/2010
1	HLA-DRB1 Chains (HLA DRB1)IBA 04/2008
1	HomocysteineIBA 04/2008
1	Methylenetetrahydrofolate Reductase (NADPH2) (Methylenetetrahydrofolate Reductase)IBA 04/2008
1	Viral RNAIBA 01/2006

Therapy/Procedure

2	Therapeutics 02/2006 - 12/2005
1	Retreatment 01/2018
1	Highly Active Antiretroviral Therapy (HAART) 01/2017